‘Tumor escape’ could be eradicated through Tessa, St. Jude partnership

By , Daily Memphian Updated: September 24, 2018 12:37 PM CT | Published: September 24, 2018 10:40 AM CT
St. Jude Children’s Research Hospital is collaborating with a Singapore-based clinical stage biopharmaceutical company to develop a novel way of using a patient’s immune system to fight cancer.


Giedre Krenciute Jean-Yves Metais St. Jude Children's Research Hospital Stephen Gottschalk
Michelle Corbet

Michelle Corbet

Michelle Corbet covers business for The Daily Memphian. Prior to, she was a reporter at the Memphis Business Journal. A native Memphian and University of Memphis graduate, Michelle covered business in Conway, Arkansas after college. Michelle got her start covering business as an intern at The Commercial Appeal.


Want to comment on our stories? Or read the comments of others? Join the conversation by subscribing now. Only subscribers can view or add comments. Our commenting policy can be viewed here